1. Home
  2. PK vs TXG Comparison

PK vs TXG Comparison

Compare PK & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Hotels & Resorts Inc.

PK

Park Hotels & Resorts Inc.

N/A

Current Price

$10.42

Market Cap

2.3B

Sector

Real Estate

ML Signal

N/A

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

N/A

Current Price

$19.88

Market Cap

2.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PK
TXG
Founded
1946
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Laboratory Analytical Instruments
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.3B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
PK
TXG
Price
$10.42
$19.88
Analyst Decision
Hold
Hold
Analyst Count
11
14
Target Price
$11.36
$17.18
AVG Volume (30 Days)
3.2M
2.2M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
9.74%
N/A
EPS Growth
N/A
76.97
EPS
N/A
N/A
Revenue
$2,791,000,000.00
$245,893,000.00
Revenue This Year
$2.44
N/A
Revenue Next Year
$2.49
$7.26
P/E Ratio
N/A
N/A
Revenue Growth
2.35
68.06
52 Week Low
$8.27
$6.78
52 Week High
$12.39
$23.56

Technical Indicators

Market Signals
Indicator
PK
TXG
Relative Strength Index (RSI) 41.60 51.93
Support Level $10.01 $11.62
Resistance Level $10.97 $20.62
Average True Range (ATR) 0.34 1.23
MACD -0.03 -0.10
Stochastic Oscillator 21.66 56.19

Price Performance

Historical Comparison
PK
TXG

About PK Park Hotels & Resorts Inc.

Park Hotels & Resorts owns upper-upscale and luxury hotels, with 22,395 rooms across 36 hotels in the United States. Park also has interests through joint ventures in another 2,271 rooms in three US hotels. Park was spun out of Hilton Worldwide Holdings at the start of 2017, so most of its hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: